2023 ACA Philadelphia Program Book_153rd Congress of Correction

extrapolated from a study done in 2018 after the implementation of the program will be presented along with goals aimed at developing the program in the future. Learning Objectives: • Describe the problems associated with opioid use disorder (OUD) and opioid overdose related deaths in the context of the opioid epidemic and the pandemic. • Discuss medications used to treat OUD and the use of buprenorphine in correctional settings. • Describe the impact of providing buprenorphine to incarcerated persons within the Philadelphia Department of Prisons. Moderator: Vandelyn T. Phillips , BSN, RN, CCHP, Vice President of Operations, Philadelphia Department of Prisons, Philadelphia, Pennsylvania Speakers: Xavier D. Beaufort Sr. , Deputy Commissioner of Administration, Philadelphia Department of Prisons, Philadelphia, Pennsylvania; Dorian Jacobs , M.D., Director of Addiction Medicine, Riverside Correctional Facility, Philadelphia, Pennsylvania

oxygen supply into your system. When a person stops breathing, the Apnea Hypopnea Index (AHi), gets high potentially causing strokes, heart attacks and other systemic collapse due to lack of oxygen. Improving airway through myofunctional therapy, Oral appliances, epigenetics and pneumopedic engineering will relieve those with OSA from the lifetime use of the C-PAP machine. Myofunctional therapy and breathing wellness will be beneficial in corrections, it does not require surgery or medication. Learning Objectives: • How Myofunctional and Breathing wellness will improve OSA treatment for the inmate population without surgery or medication. • Benefits of the Continuous Positive Air Pressure (C-PAP) machine, the only equipment that save lives for people suffering from obstructive sleep apnea which are available to the inmate population. • Increase awareness among healthcare providers in prevention of obstructive sleep apnea. Treating the root cause of OSA will save lives. Moderator: James H. Clare , DDS, MPH, HP, Chief Dental Officer, North Carolina Department of Adult Correction, Raleigh, North Carolina Speaker: Juana R. Cavinder , DDS, Airway Dentistry, Valley Center, California A-4L Treatment of Opioid Disorder in Philadelphia Department of Prisons (CE) Track: Nursing Room 203-B This presentation aims to describe the Medications for Opioid Use Disorder (MOUD) treatment program that is in place within the Philadelphia Department of Prisons correctional facilities. Relevant data that describes the current opioid epidemic both nationwide and locally will be presented along with corresponding statistics about incarcerated populations in Philadelphia. Descriptions of how the program is run along with information about the medications and protocols used within the program will be covered. Lastly, impact data

Thursday, Aug. 10 ▼ 4–5:30 p.m.

WORKSHOPS

94 — ACA 153 rd Congress of Correction | Philadelphia